CGB-400 / CAGE Bio - LARVOL DELTA

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea (clinicaltrials.gov) - P2 | N=78 | Completed | Sponsor: CAGE Bio Inc. | Recruiting ➔ Completed

Trial completion • Dermatology • Rosacea

An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection (clinicaltrials.gov) - P=N/A | N=15 | Recruiting | Sponsor: CAGE Bio Inc. | Active, not recruiting ➔ Recruiting

Enrollment open • Dermatology • Infectious Disease

An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection (clinicaltrials.gov) - P=N/A | N=15 | Active, not recruiting | Sponsor: CAGE Bio Inc. | Not yet recruiting ➔ Active, not recruiting

Enrollment closed • Dermatology • Infectious Disease

An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection (clinicaltrials.gov) - P=N/A; N=15; Not yet recruiting; Sponsor: CAGE Bio Inc.

Clinical • New trial • Dermatology • Infectious Disease

Clinical translation of choline and geranic acid deep eutectic solvent. (PubMed, Bioeng Transl Med) - "Our translational efforts led to a 12-week open-label phase 1b cosmetic study with CAGE gel (CGB400) in mild-moderate facial rosacea in 26 patients where CGB400 exhibited a marked reduction in the number of inflammatory lesions. These results demonstrate the therapeutic potential of CGB400 for treating rosacea as well as it provides insights into the translational journey of deep eutectic solvents, in particular CAGE, for dermatological applications."

Clinical • Journal • Dermatology • Inflammation • Rosacea

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea (clinicaltrials.gov) - P2; N=80; Recruiting; Sponsor: CAGE Bio Inc.

Clinical • New P2 trial • Dermatology • Rosacea

CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes (clinicaltrials.gov) - P1; N=27; Completed; Sponsor: CAGE Bio Inc.

New P1 trial • Dermatology • Dermatopathology • Rosacea

CGB-400 for the Reduction of Facial Redness (clinicaltrials.gov) - P1; N=25; Completed; Sponsor: CAGE Bio Inc.

New P1 trial • Dermatology • Dermatopathology • Rosacea